TR200102306T2 - Faktör Xa önleyici olarak heterosiklik türevler. - Google Patents

Faktör Xa önleyici olarak heterosiklik türevler.

Info

Publication number
TR200102306T2
TR200102306T2 TR2001/02306T TR200102306T TR200102306T2 TR 200102306 T2 TR200102306 T2 TR 200102306T2 TR 2001/02306 T TR2001/02306 T TR 2001/02306T TR 200102306 T TR200102306 T TR 200102306T TR 200102306 T2 TR200102306 T2 TR 200102306T2
Authority
TR
Turkey
Prior art keywords
heterocyclic derivatives
inhibitor
factor
thrombotic
relates
Prior art date
Application number
TR2001/02306T
Other languages
English (en)
Inventor
William Rodney Caulkett Peter
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200102306T2 publication Critical patent/TR200102306T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Söz konusu bulus formül I'e uygun heterosiklik türevler ya da bunlarin farmasötik olarak kabul edilir tuzlari ile ilgili olup, anti-trombotik ve anti-koagülan hususiyetlere sahip ve insanlarin ve hayvanlarin tedavi edilme yöntemlerinde faydalidir. Bulus ayrica heterosiklik türevleri ihtiva eden farmasötik bilesimlerin hazirlanmasi ve bunlarin anti-trombotik ve anti-koagülan bir etkiye sahip ilaçlarin imalatinda kullanilmasi ile de ilgilidir.
TR2001/02306T 1999-02-11 2000-02-08 Faktör Xa önleyici olarak heterosiklik türevler. TR200102306T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9902989.4A GB9902989D0 (en) 1999-02-11 1999-02-11 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
TR200102306T2 true TR200102306T2 (tr) 2001-12-21

Family

ID=10847476

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02306T TR200102306T2 (tr) 1999-02-11 2000-02-08 Faktör Xa önleyici olarak heterosiklik türevler.

Country Status (24)

Country Link
US (1) US6723723B1 (tr)
EP (1) EP1150974B1 (tr)
JP (1) JP2002536443A (tr)
KR (1) KR20010102072A (tr)
AT (1) ATE223402T1 (tr)
AU (1) AU757738B2 (tr)
BR (1) BR0008130A (tr)
CA (1) CA2362392A1 (tr)
CZ (1) CZ20012867A3 (tr)
DE (1) DE60000410T2 (tr)
DK (1) DK1150974T3 (tr)
ES (1) ES2181637T3 (tr)
GB (1) GB9902989D0 (tr)
HU (1) HUP0105102A3 (tr)
IL (1) IL144792A0 (tr)
NO (1) NO20013921L (tr)
NZ (1) NZ513350A (tr)
PL (1) PL349220A1 (tr)
PT (1) PT1150974E (tr)
RU (1) RU2226193C2 (tr)
SK (1) SK11462001A3 (tr)
TR (1) TR200102306T2 (tr)
WO (1) WO2000047573A1 (tr)
ZA (1) ZA200106337B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
WO2003000657A1 (fr) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Derives de diamine
JP4744149B2 (ja) 2002-12-03 2011-08-10 ファーマサイクリックス インコーポレイテッド 第ｖｉｉａ因子阻害剤としての２−（２−ヒドロキシビフェニル−３−イル）−１ｈ−ベンゾイミダゾール−５−カルボキサミジン誘導体
WO2006109817A1 (ja) * 2005-04-06 2006-10-19 Banyu Pharmaceutical Co., Ltd. １，４－置換ピペラジン誘導体
JP5214096B2 (ja) * 2005-06-17 2013-06-19 富士フイルムファインケミカルズ株式会社 新規なビピリジン誘導体
BR112021026410A2 (pt) 2019-07-01 2022-02-08 Tonix Pharma Ltd Anticorpos anti-cd154 e usos dos mesmos
CN116963750A (zh) 2021-01-06 2023-10-27 通尼克斯制药有限公司 用经修饰的抗-cd154抗体诱导免疫耐受的方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT340933B (de) 1973-08-20 1978-01-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
US4167567A (en) 1978-05-05 1979-09-11 The Upjohn Company Antihypertensive 4-aminoquinolines
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
SE8203887D0 (sv) 1982-06-23 1982-06-23 Kabivitrum Ab Nya trombininhiberande foreningar
DE3246932A1 (de) 1982-12-16 1984-06-20 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte 5h-pyrimido(5,4-b)indole
FR2557570B1 (fr) 1984-01-04 1986-04-18 Adir Nouveaux derives de la quinoleine, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4840963A (en) 1984-03-14 1989-06-20 Merck & Co., Inc. 2-Sulfamoyl-1H-indole derivatives for the treatment of elevated intraocular pressure
GB8601160D0 (en) 1986-01-17 1986-02-19 Fujisawa Pharmaceutical Co Heterocyclic compounds
GB8603120D0 (en) 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609630D0 (en) 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
GB8710494D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Antiarrhythmic agents
JPH0696575B2 (ja) 1987-09-17 1994-11-30 三菱化成株式会社 ４−アミノピリジン誘導体及びその酸付加塩
US4871721A (en) 1988-01-11 1989-10-03 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors
GB8817315D0 (en) 1988-07-20 1988-08-24 Pfizer Ltd Triazole antifungal agents
GB8819307D0 (en) 1988-08-13 1988-09-14 Pfizer Ltd Antiarrhythmic agents
DE3905364A1 (de) 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
GB8905526D0 (en) 1989-03-10 1989-04-19 Fujisawa Pharmaceutical Co N-containing heterocyclic compounds,processes for the preparation thereof and composition comprising the same
IE64358B1 (en) 1989-07-18 1995-07-26 Ici Plc Diaryl ether heterocycles
US5032604A (en) 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
DE3943225A1 (de) 1989-12-23 1991-06-27 Schering Ag Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln
AU8868991A (en) 1990-11-15 1992-06-11 Pentapharm Ag Meta-substituted phenyl alanine derivatives
EP0495750A3 (en) 1991-01-14 1992-09-16 Ciba-Geigy Ag Heterocyclic hydroxylamine
IT1245712B (it) 1991-04-09 1994-10-14 Boehringer Mannheim Italia Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree
FR2676054B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1993000342A1 (en) 1991-06-21 1993-01-07 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
CA2119467A1 (en) 1991-09-19 1993-04-01 Pamela Anne Chambers Pyridine compounds for treating leukotriene-related diseases
US5541330A (en) 1991-12-10 1996-07-30 Eastman Kodak Company Ion-sensitive compounds
PH31294A (en) 1992-02-13 1998-07-06 Thomae Gmbh Dr K Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
HU211995B (en) 1992-06-30 1996-01-29 Gyogyszerkutato Intezet Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them
US5371091A (en) 1992-08-31 1994-12-06 Bristol-Myers Squibb Company Heteroaromatic amine thrombin inhibitors
FR2697252B1 (fr) 1992-10-28 1994-12-09 Fournier Ind & Sante Dérivés de 1,2,3,5,6,7,8,8a-octahydro-5,5,8a-triméthyl-(8abeta)-6-isoquinolineamine, leur procédé de préparation et leur utilisation en thérapeutique.
DE4243858A1 (de) 1992-12-23 1994-06-30 Thomae Gmbh Dr K Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5332822A (en) 1992-12-24 1994-07-26 Bristol-Myers Squibb Company Heteroaromatic and thioheteroaromatic substituted sulfonamide thrombin inhibitors
US5364865A (en) 1992-12-30 1994-11-15 Sterling Winthrop Inc. Phenoxy- and phenoxyalkyl-piperidines as antiviral agents
DE4302485A1 (de) 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazinderivate
AU5878194A (en) 1993-02-10 1994-08-29 Pentapharm Ag Piperazides of substituted phenylalanine derivates as thrombin inhibitors
DE4306506A1 (de) 1993-03-03 1994-09-08 Boehringer Mannheim Gmbh Neue 4-Alkylaminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
TW257757B (tr) 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
DE4306873A1 (de) 1993-03-05 1994-09-08 Boehringer Mannheim Gmbh Neue 4-Aminopyridine-Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
CN1120334A (zh) 1993-03-29 1996-04-10 曾尼卡有限公司 用作血小板凝聚抑制剂的杂环衍生物
NZ262942A (en) 1993-03-29 1997-07-27 Zeneca Ltd Pyridyl substituted piperazine and various other derivatives of azaheteroaryl substituted piperazines; pharmaceutical compositions
US5681954A (en) 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
AU3107795A (en) 1994-08-09 1996-03-07 Pentapharm Ag Inhibitors of the benzamidine type
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
US6037343A (en) 1994-12-22 2000-03-14 Smithkline Beecham Corporation Fibrinogen receptor antagonists
EP0801650A4 (en) 1994-12-22 1998-05-06 Smithkline Beecham Corp FIBRINOGEN RECEPTOR ANTAGONISTS
IL117149A0 (en) 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
US5856326A (en) 1995-03-29 1999-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
IL117580A0 (en) 1995-03-29 1996-07-23 Merck & Co Inc Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
IT1282797B1 (it) 1995-04-21 1998-03-31 Colla Paolo Pirril-(indolil)-aril-sulfoni e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids
GB9516709D0 (en) 1995-08-15 1995-10-18 Zeneca Ltd Medicament
GB9602166D0 (en) 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
JP2000504336A (ja) 1996-02-02 2000-04-11 ゼネカ・リミテッド 薬学製剤として有用なヘテロ環式化合物
GB9602294D0 (en) 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
EP0892780B1 (en) 1996-02-22 2002-11-20 Bristol-Myers Squibb Pharma Company M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
IL128428A0 (en) 1996-08-14 2000-01-31 Zeneca Ltd Substituted pyrimidine derivatives and their pharmaceutical use
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
WO1998035956A1 (en) 1997-02-13 1998-08-20 Zeneca Limited Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
AU5999798A (en) 1997-02-13 1998-09-08 Zeneca Limited Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
GB9715894D0 (en) * 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic derivatives
GB9715892D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
GB9809349D0 (en) 1998-05-02 1998-07-01 Zeneca Ltd Heterocyclic derivatives
KR20010043246A (ko) 1998-05-02 2001-05-25 다비드 에 질레스 Ｘａ 인자를 억제시키는 헤테로시클릭 유도체

Also Published As

Publication number Publication date
EP1150974B1 (en) 2002-09-04
US6723723B1 (en) 2004-04-20
ATE223402T1 (de) 2002-09-15
JP2002536443A (ja) 2002-10-29
DE60000410D1 (de) 2002-10-10
CZ20012867A3 (cs) 2001-10-17
CA2362392A1 (en) 2000-08-17
AU757738B2 (en) 2003-03-06
PL349220A1 (en) 2002-07-01
AU2447000A (en) 2000-08-29
NZ513350A (en) 2003-01-31
GB9902989D0 (en) 1999-03-31
PT1150974E (pt) 2003-01-31
BR0008130A (pt) 2002-02-05
HUP0105102A2 (hu) 2002-05-29
DE60000410T2 (de) 2003-06-05
NO20013921L (no) 2001-10-10
KR20010102072A (ko) 2001-11-15
HUP0105102A3 (en) 2003-01-28
IL144792A0 (en) 2002-06-30
NO20013921D0 (no) 2001-08-10
SK11462001A3 (sk) 2001-12-03
DK1150974T3 (da) 2002-12-02
RU2226193C2 (ru) 2004-03-27
WO2000047573A1 (en) 2000-08-17
EP1150974A1 (en) 2001-11-07
ZA200106337B (en) 2002-11-01
ES2181637T3 (es) 2003-03-01

Similar Documents

Publication Publication Date Title
TR200000223T2 (tr) XA faktörünü engelleyen heterosiklik türevler
TR199901006T2 (tr) Heterosiklik türevler.
TR199801530T2 (tr) VEGF Inhibitörleri olarak kinazolin türevleri.
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
DE60010076D1 (de) Chinolinderivate als antibakterielle mittel
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BR9811818A (pt) Uso de um composto, composto, e, composição farmacêutica
EE200000527A (et) Faktorit Xa pärssivad heterotsüklilised derivaadid
TR200101649T2 (tr) Piperazin türevleri.
ATE287874T1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
TR200102306T2 (tr) Faktör Xa önleyici olarak heterosiklik türevler.
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
EE200200088A (et) Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks
TR200200485T2 (tr) Yeni A-500359 türevleri.
ATE299027T1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
TR199801835A2 (tr) Antimikrobiyal kompozisyonlar.
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.